Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Forecasted Growth Rate and Market Size of the Peptide Therapeutics Market?

The market size for quinine sulfate has been on a significant upswing in recent years. There’s predicted growth from $2.41 billion in 2024 to $2.59 billion in 2025, resulting from a compound annual growth rate (CAGR) of 7.5%. This growth experienced during the historic period has their roots in the escalating prevalence of malaria, the increasing requirement for anti-malarial treatments, the expansion of pharmaceutical manufacturing, a growing recognition of quinine’s medicinal applications, and the escalated demand in tropical zones.

Significant escalation is anticipated in the quinine sulfate market size over the forthcoming years, expected to reach “$3.52 billion in 2029 with a compound annual growth rate (CAGR) of 8.0%. This predicted growth throughout the forecasted period is due to an enhanced concentration on the treatment of tropical diseases, an uplift in health expenses across developing countries, the demand for muscle relaxant medicines, a growing populace in areas where malaria is endemic, and improvements in the supply chain for unprocessed materials. Key emerging trends throughout the projected period encompass a rising demand for generic anti-malarial medications, increased investment in healthcare in emerging markets, technological advancements in pharmaceutical manufacturing, an intensified regulatory focus on drug safety, and a heightened global emphasis on malaria eradication strategies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19165&type=smp

Which Factor Is Shaping The Future Of The Peptide Therapeutics Market?

The rise in chronic diseases is projected to boost the peptide therapeutics market’s growth. Chronic diseases, often incurable or long-lasting, are sometimes manageable and treated. Factors such as the growing consumption of tobacco products, poor diet, lack of exercise, and excessive alcohol use are contributing to the rise of chronic diseases. Peptide therapeutics plays a significant role in preventing and treating some of these chronic diseases. For example, the National Library of Medicine, a US-based agency, anticipates that by January 2023, the number of US individuals aged 50 and up with at least one chronic illness will surge by 99.5%, reaching 142.66 million by 2050. Consequently, the rising prevalence of chronic diseases is set to fuel the peptide therapeutics market in the forecast period.

The quinine sulfate market covered in this report is segmented –

1) By Type: 200mg, 300mg, Other Types

2) By Product: Quinine Sulfate Tablets, Quinine Sulfate Capsules, Quinine Sulfate Injections, Quinine Sulfate Powder, Quinine Sulfate Oral Solutions

3) By Distribution Channel: Hospitals, Retail Pharmacies, Online Pharmacies

4) By Application: Malaria, Problematic Leg Cramps, Lupus, Rheumatoid Arthritis, Other Applications

5) By End-User: Adults, Pediatrics, Geriatrics

Subsegments:

1) By 200 mg: Tablets, Oral Solutions, Capsules

2) By 300 mg: Tablets, Oral Solutions, Capsules

3) Other Types: Injectable Forms, Extended Release Formulations, Combination Products

What Are The Leading Trends And Opportunities In The Peptide Therapeutics Sector?

Key players in the quinine sulfate market are prioritizing the creation of innovative solutions such as effective quinine synthesis and its derivatives to optimize the production process, decreasing costs, waste, and time, while improving their chemical synthesis abilities. The quinine sulfate synthesis method encompasses chemical procedures to reproduce the compound artificially, paralleling its natural extraction from the bark of the cinchona tree. This process is conducive to the large-scale manufacturing of the anti-malaria medication. An illustration of this is the efficient enantioselective synthesis of quinine accomplished by the Japan-based Tohoku University in December 2022. This research included a one-pot synthesis of quinine and its derivatives using organocatalysts to optimize the process and decrease the necessary steps. This progress is crucial as it diminishes chemical waste, reduces production time, and has the potential to decrease costs, advancing the production of new treatments and enhancing overall synthesis efficacy.

Which Companies Hold The Largest Market Share In The Peptide Therapeutics Sector?

Major companies operating in the quinine sulfate market are Sanofi SA, Thermo Fisher Scientific Inc., Viatris Inc., Teva Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Dr. Reddy’s Laboratories, Cipla Limited, Lupin Limited, Strides Pharma, Taj Pharmaceuticals, Wockhardt Ltd., Alchem International Private Limited, SimSon Pharma Limited, Hangzhou Dayang Co. Ltd., Haihang Industry Co. Ltd., Pharmakina SA, Aecochem Corp, Buchler GmbH, Prism Industries Private Limited, Shreeji Pharma International, Trademax Pharmaceuticals & Chemicals, Sihauli Chemicals Private Limited

https://www.thebusinessresearchcompany.com/report/quinine-sulfate-global-market-report

How Does Regional Performance Compare Across The Peptide Therapeutics Industry?

Asia-Pacific was the largest region in the quinine sulfate market in 2024. The regions covered in the quinine sulfate market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=19165&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model